In vitro activities of antifungal drugs against yeasts isolated from blood cultures and moulds isolated from various clinically significant sites in Singapore

Annals of the Academy of Medicine Singapore

Volumn 37, Issue 10, 2008, Pages 841-846

  Ai, Ling Tan ^a   Kian, Sing Chan ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Antifungal susceptibility; Aspergillus; Candida; Etest; Singapore

Indexed keywords

ANTIFUNGAL AGENT; CASPOFUNGIN; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS; BLOOD; BLOOD CULTURE; CEREBROSPINAL FLUID; CRYPTOCOCCUS; DRUG ACTIVITY; EPSILOMETER TEST; FUNGEMIA; MINIMUM INHIBITORY CONCENTRATION; MOULD; NONHUMAN; SINGAPORE; YEAST;

EID: 56449118528     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 2006;43:25-31.
2. Nucci M, Marr KA. Emerging fungal diseases. Clin Infect Dis 2005;41:521-6.
3. Rex JH, Pfaller MA, Rinaldi MG, Polak A, Galgiani JN. Antifungal susceptibility testing. Clin Microbiol Rev 1993;6:367-81.
4. Rex JH, Pfaller MA, Walsh TJ, Chaturvedi V, Espinel-Ingroff A, Ghannoum MA, et al. Antifungal susceptibility testing: practical aspects and current challenges. Clin Microbiol Rev 2001;14:643-58.
5. Oon LLE, Yeo MCG. Fluconazole susceptibility of candida species in Singapore by disc diffusion test. Ann Acad Med Singapore 2002;31:497-501.
6. Yang CW, Barkham TM, Chan FY, Wang Y. Prevalence of Candida species, including Candida dubliniensis, in Singapore. J Clin Microbiol 2003;41:472-4.
7. Customer Information Sheet Media for Antifungal Suceptibility Testing CIS 005, AB Biodisk, Sweden.
8. Etest Application Sheet for Yeast EAS 006. AB Biodisk, Dalvagen 10, S-169 56 Solna, Sweden.
9. Antifungal Susceptibility Testing of Moulds. Etest Technical guide 10. AB Biodisk, Sweden.
10. Etest Application Sheet for Mould EAS 012. AB Biodisk, Dalvagen 10, S-169 56 Solna, Sweden.
11. Quality Control Minimal Inhibitory Concentration (MIC) Limits for Broth Microdilution and MIC Interpretative Breakpoints. Clinical and Laboratory Standards Institute document number M27-S2.
12. Pfaller MA, Messer, Holis RJ, Jones RN and the Sentry Participants Group. Antifungal activities of posaconazole, ravuconazole and voriconazole compared to those of itraconazole and amphotericin b against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000. Antimicrob Agents Chemother 2002;46:1032-7.
13. Goodwin ML, Drew RH. Antifungal serum concentration monitoring: an update. J Antimicrob Chemother 2008;61:17-25.